Actinium to Host Key Opinion Leader Event Focused on Bone Marrow Transplant, Potential Role of Iomab-B on May 12 May 12, 2015
Actinium to Host Key Opinion Leader Event Focused on Bone Marrow Transplant, Potential Role of Iomab-B on May 12 May 6, 2015
Actinium to Co-Sponsor, Provide Clinical Update at Upcoming Targeted Alpha Therapy Symposium Apr 29, 2015
Actinium to Partner With Aplastic Anemia & MDS International Foundation Patient and Family Forums Apr 22, 2015
Actinium Pharmaceuticals Opens Enrollment for the Fourth and Final Cohort in the Company's Ongoing Phase I/II Trial in Acute Myeloid Leukemia Mar 24, 2015
Actinium Announces New Data From Ongoing Phase 1/2 Trial of Actimab-A Demonstrating Safety and Robust Clinical Efficacy in High Risk Elderly Acute Myeloid Leukemia Patients Mar 18, 2015
Actinium to Present at the 22nd Annual Future Leaders in the Biotech Industry Conference March 20th in New York City Mar 16, 2015
